SCHEMBL598772

SCHEMBL598772

CCCC(C)C(C)C(C)C

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.37
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20609978 0.90 METAP1 (0.36) METAP1TSHR
SCHEMBL82074 0.86
SCHEMBL15141735 0.86
SCHEMBL15141862 0.86
SCHEMBL20609967 0.86 TSHR (0.40) METAP1TSHR
SCHEMBL16031465 0.83 TSHR (0.42) TSHR
Ammonia Solution, Strong SCHEMBL28520433 0.83
Water SCHEMBL10632099 0.83
SCHEMBL15238771 0.81 DNM1 (0.39) TSHR
SCHEMBL1028502 0.79 OPRM1 (0.48) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER BIOSYNTHIS (FR) 2024-05-02 US claimed
EP-4321651-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXO ESTER Biosynthis (FR) 2024-02-14 EP claimed
EP-3846691-A2 SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING Kozhnosys Private Limited (IN) 2021-07-14 EP claimed
US-20210186367-A1 SYSTEM FOR DETECTION OF VOLATILE ORGANIC COMPOUNDS (VOC) IN EXHALED BREATH FOR HEALTH MONITORING KOZHNOSYS PRIVATE LIMITED (IN) 2021-06-24 US claimed
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 EP claimed
US-9315602-B2 Method for producing olefin polymer MITSUI CHEMICALS, INC. (JP) 2016-04-19 US claimed
WO-2013173332-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN Vertichem Corporation (CA) 2013-11-21 WO claimed
US-20130232853-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN THESIS CHEMISTRY, LLC (US) 2013-09-12 US claimed
US-20130232852-A1 METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN THESIS CHEMISTRY, LLC (US) 2013-09-12 US claimed
WO-2013134756-A1 A METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN Vertichem Corporation (CA) 2013-09-12 WO claimed
US-12616728-B2 Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same SUPER CRITICAL IP, LLC (US) 2026-05-05 US disclosed
US-20260041617-A1 COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES BIOSYNTHIS (FR) 2026-02-12 US disclosed
US-20250197341-A1 METHOD FOR INHIBITING CRYSTALLISATION BIOSYNTHIS (FR) 2025-06-19 US disclosed
US-20250177263-A1 LIPSTICK COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES BIOSYNTHIS (FR) 2025-06-05 US disclosed
US-20250170037-A1 EYE MAKEUP COMPOSITION BASED ON A VOLATILE MIXTURE OF ALKANES BIOSYNTHIS (FR) 2025-05-29 US disclosed
WO-2003063771-A2 N4-ACYLCYTOSINE NUCLEOSIDES FOR TREATMENT OF VIRAL IINFECTIONS PHARMASSET LTD. (BB) 2003-08-07 WO disclosed
WO-2003051298-A2 PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHESIS OF ANTIVIRAL NUCLEOSIDES PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
WO-2003051306-A2 N4-ACYLCYTOSINE-1,3-DIOXOLANE NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS PHARMASSET LTD. (BB) 2003-06-26 WO disclosed
US-5066696-A Tertiary-Alkyl-Substituted Melamines ROHM AND HAAS COMPANY (US) 1991-11-19 US disclosed
EP-0442680-A1 Polymers stabilized against light and heat degradation ROHM AND HAAS COMPANY (US) 1991-08-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616728-B2 Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same CNR2, CNR1, SCD METAP1 4478/4885TSHR 2794/4885
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER ALKBH2, ABHD12, FAAH2 METAP1 4296/4885TSHR 3034/4885
US-20260041617-A1 COSMETIC COMPOSITION APPLICABLE TO THE SKIN AND BASED ON A VOLATILE MIXTURE OF ALKANES CUTA, AP2M1, LBR METAP1 2676/4885TSHR 612/4885
US-20130232852-A1 METHOD FOR TIERED PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM LIGNIN DCXR, AGL, GLO1 METAP1 2318/4885TSHR 4782/4885
US-20130232853-A1 METHOD FOR SELECTIVE PRODUCTION OF BIOBASED CHEMICALS AND BIOFUELS FROM PLANT LIGNIN HAAO, HAO2, HACL2 METAP1 2487/4885TSHR 4699/4885
US-20250197341-A1 METHOD FOR INHIBITING CRYSTALLISATION FASN, SCD5, NFKB2 METAP1 4183/4885TSHR 3901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.